BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35425701)

  • 21. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
    Zhang J; He DH; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2014; 13(19):3143-9. PubMed ID: 25486573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration.
    Wang Y; Zhou D; Kong Y; Yang Q; Ding Y; Wang W
    Biomed Res Int; 2022; 2022():6109052. PubMed ID: 36582601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner.
    Wang T; Zhang C; Wang S
    J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
    Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
    Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC).
    Sun Y; Cao S; Li Z; Liu X; Xu J; Tian Y; Shen S; Zhou Y
    Int J Med Sci; 2021; 18(9):2051-2062. PubMed ID: 33850476
    [No Abstract]   [Full Text] [Related]  

  • 29. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.
    Li SS; Jiang WL; Xiao WQ; Li K; Zhang YF; Guo XY; Dai YQ; Zhao QY; Jiang MJ; Lu ZJ; Wan R
    World J Gastrointest Oncol; 2019 Aug; 11(8):599-621. PubMed ID: 31435462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Wang W; Yan L; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
    Front Oncol; 2020; 10():618215. PubMed ID: 33718118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
    Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
    PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism.
    Muniyan S; Haridas D; Chugh S; Rachagani S; Lakshmanan I; Gupta S; Seshacharyulu P; Smith LM; Ponnusamy MP; Batra SK
    Genes Cancer; 2016 Mar; 7(3-4):110-124. PubMed ID: 27382435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
    Pu N; Chen Q; Gao S; Liu G; Zhu Y; Yin L; Hu H; Wei L; Wu Y; Maeda S; Lou W; Yu J; Wu W
    Ann Transl Med; 2019 Nov; 7(22):645. PubMed ID: 31930046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic biomarker for pancreatic ductal adenocarcinoma: hsa_circ_0001649.
    Jiang Y; Wang T; Yan L; Qu L
    Gene; 2018 Oct; 675():88-93. PubMed ID: 29969694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Xu M; Liang H; Li K; Zhu S; Yao Z; Xu R; Lin N
    Aging (Albany NY); 2021 Feb; 13(4):5263-5283. PubMed ID: 33535183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.
    Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X
    Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
    Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
    Front Oncol; 2020; 10():49. PubMed ID: 32117719
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
    Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
    Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.